Liver Transplant Surgery Recovery, Weeks 1–2: Intensive Inpatient and Early Post-Discharge Recovery
Weeks 1–2 after liver transplant surgery make up phase 1 of 4 in a typical 16-week recovery: Intensive Inpatient and Early Post-Discharge Recovery. Your own surgeon's instructions always come first.
Goals for weeks 1–2
- The transplanted liver begins functioning immediately upon reperfusion, and the evidence of its function is visible in the laboratory values that your team monitors multiple times daily during the initial hospitalization. Liver enzymes (AST and ALT) will be markedly elevated in the first 24 to 48 hours — this reflects the ischemia-reperfusion injury that every transplanted organ sustains and is expected. These values should decline steadily over the first week. Bilirubin, which was often severely elevated before transplant, begins to fall as the new liver clears the accumulated pigment. The coagulation system, entirely dependent on hepatic synthesis of clotting factors, begins normalizing within hours of reperfusion — the INR and fibrinogen are tracked closely as markers of synthetic function. Albumin, also liver-synthesized, rises more slowly over weeks.
- Primary graft non-function — a failure of the transplanted liver to work at all — is a rare but catastrophic event that presents within the first 48 to 72 hours with persistent coagulopathy, rising bilirubin, hemodynamic instability, and progressive organ failure. It requires urgent relisting and re-transplantation. Your ICU team monitors for this constantly in the early hours, and the recognition that the graft is functioning and improving is one of the first major reassurances of the post-operative period.
- The coagulopathy of end-stage liver disease is a complex disorder involving deficiencies of both pro-coagulant and anti-coagulant factors. After transplant, the new liver must synthesize the full complement of coagulation proteins, which happens over days to weeks. During this transition, the coagulation status is labile — patients may be simultaneously at risk for bleeding (from factor deficiency and surgical sites) and thrombosis (from protein C and S deficiency, immobility, and the pro-thrombotic milieu of major surgery). INR is monitored daily or more frequently, and blood products (fresh frozen plasma, cryoprecipitate, platelets) are administered as needed. Anticoagulation for DVT prophylaxis must be carefully timed relative to the coagulation status, and the transplant team manages this balance closely.
- The biliary anastomosis is monitored through clinical assessment, liver function tests, and imaging. A bile leak presents with bilious drainage from surgical drains (a critical piece of information that makes drain output assessment important), abdominal pain, fever, or rising bilirubin after initial improvement. A biliary stricture typically presents later, with gradually rising bilirubin and alkaline phosphatase. If a T-tube was placed at surgery (less common in modern practice but still used at some centers), it provides direct access to the biliary system for cholangiography and decompression. T-tube management requires specific instructions from your surgical team regarding clamping schedules, output recording, and care of the external portion.
- Most liver transplant recipients leave the operating room with multiple Jackson-Pratt (JP) drains positioned around the liver. These drains serve the critical function of evacuating blood, serous fluid, and — importantly — of revealing bilious fluid that would indicate a bile leak. You or your nursing team will record the volume and character of drain output multiple times daily. A sudden increase in output, a change from serosanguineous to bilious (dark green or golden-yellow) fluid, or frankly bloody output should be reported immediately. Drains are typically removed sequentially as output decreases and character remains non-bilious, usually over the first 1 to 3 weeks. Some patients go home with drains in place, requiring home management with daily recording and regular follow-up for assessment.
- Many liver transplant recipients are profoundly malnourished at the time of surgery. The combination of cirrhosis-induced anorexia, impaired nutrient absorption, altered metabolism, protein losses from ascites, and the catabolic effects of chronic liver disease means that muscle mass and nutritional reserves are often severely depleted. Nutritional rehabilitation begins in the ICU with early enteral feeding (often via a nasogastric or nasojejunal tube if oral intake is not feasible) and transitions to oral intake as soon as the patient is able. Protein requirements are high — typically 1.5 to 2.0 grams per kilogram of ideal body weight daily — to support wound healing, immune function, and the anabolic recovery that the functioning graft now makes possible.
- Caloric intake should be generous (25-35 kcal/kg/day) in the early weeks to reverse the catabolic state. Dietary sodium restriction (less than 2 grams daily) continues initially, particularly if ascites persists — and it often does for weeks after transplant, resolving gradually as the new liver normalizes portal pressures and albumin levels rise. Small, frequent meals are often better tolerated than large ones given the combination of reduced stomach capacity (compressed by the enlarged liver pre-transplant), post-surgical ileus, and medication-related nausea. A transplant dietitian should be involved from the earliest days of recovery.
- Immunosuppressive management in liver transplant follows the same general principles as kidney transplant (triple therapy with tacrolimus, mycophenolate, and prednisone), but with a critical pharmacokinetic distinction: tacrolimus is metabolized by the liver, and the recovering graft's metabolic capacity changes daily in the first weeks. This means that tacrolimus levels are inherently unstable early after transplant — the same dose can produce very different trough levels as hepatic function improves. Levels are monitored daily during hospitalization and frequently after discharge, with dose adjustments that may be needed every few days. The transplant team manages this dynamic process, and patients must communicate any changes in their condition (particularly gastrointestinal symptoms that might affect absorption) promptly.
- Getting out of bed and walking begins on post-operative day 1 or 2 in most patients, though the first steps after major liver surgery are often slow and challenging. The large abdominal incision, the presence of multiple drains, abdominal distension from residual ascites or ileus, and the general deconditioning from pre-transplant illness combine to make early mobilization difficult. It is nonetheless critically important for pulmonary function (preventing atelectasis and pneumonia), DVT prevention, and the restoration of gastrointestinal motility. Physiotherapy begins in the ICU and continues throughout hospitalization. Even small daily gains in walking distance and sitting tolerance are meaningful and cumulative.
- If ascites was present before transplant, it typically persists for days to weeks afterward. The transplanted liver must normalize portal pressures and restore albumin synthesis before the ascitic fluid is reabsorbed. Dietary sodium restriction, diuretics (if kidney function permits), and occasional therapeutic paracentesis may be needed during this transition. Progressive resolution of ascites is a reassuring sign of graft function.
- Temperature (fever threshold lower in immunosuppressed patients)
- Weight (trending for fluid shifts, ascites resolution)
- Blood pressure and heart rate
- Drain outputs: volume, color, and character for each drain (bilious output is an emergency finding)
- Abdominal circumference (if ascites present)
- Oral intake and appetite
- Medication adherence
- Wound appearance
- Mental clarity (encephalopathy assessment — orientation, handwriting, concentration)
- Blood glucose
- Stool pattern and color (acholic stools suggest biliary obstruction)
- Mood and emotional state
What to avoid in weeks 1–2
- No lifting heavier than 5 kg for 8-12 weeks (large abdominal incision, muscle healing)
- No driving until transplant team clearance
- No submersion of wounds until fully healed and drains removed
- Strict medication adherence
- Infection precautions (same as kidney transplant: hand hygiene, food safety, sick contact avoidance, mask use)
- No alcohol — absolute and lifelong, regardless of transplant indication (hepatotoxic to graft; mandatory for ALD patients)
- No NSAIDs (hepatotoxic risk plus renal concerns)
- Acetaminophen limited to 2 grams daily maximum (with functioning graft; avoid entirely if graft dysfunction)
- No herbal supplements or medications without transplant team approval
- No grapefruit (CYP3A4 interaction with tacrolimus)
Call your care team if, during weeks 1–2:
- Sudden severe right upper quadrant or epigastric pain (hepatic artery thrombosis, graft rupture)
- Jaundice that is new or worsening after initial improvement (biliary complication, rejection, or vascular event)
- Fever above 38.5C with rigors or hemodynamic compromise (sepsis in immunosuppressed patient)
- Heavy bleeding from wound, drain sites, or gastrointestinal tract
- Altered mental status or confusion (hepatic encephalopathy from graft dysfunction, infection, or medication toxicity)
- Signs of pulmonary embolism: sudden dyspnea, pleuritic chest pain, hypoxia
- Wound dehiscence or evisceration
- New-onset ascites after initial resolution (graft dysfunction, portal hypertension, vascular complication)
- Seizure (immunosuppressant toxicity, metabolic derangement)
Weeks 3–6: Wound Healing and Graft Stabilization →
See the whole recovery timeline →
Follow weeks 1–2 in Surgily
Surgily shows each day's exercises for this phase, lets you log how you feel in 30 seconds and share it with your care team, and tells you clearly when to get help.
Get my recovery plan →